ABSTRACT
BACKGROUND: Tuberous sclerosis complex (TSC) and primary lymphedema (PLE) are both rare diseases, and it is even rarer for both to occur in the same patient. In this work, we have provided a detailed description of a patient's clinical presentation, imaging findings, and treatment. And a retrospective analysis was conducted on 14 published relevant case reports. CASE SUMMARY: A 16-year-old male came to our hospital for treatment due to right lower limb swelling. This swelling is already present from birth. The patient's memory had been progressively declining. Seizures had occurred 1 year prior at an unknown frequency. The patient was diagnosed with TSC combined with PLE through multimodal imaging examination: Computed tomography, magnetic resonance imaging, and lymphoscintigraphy. The patient underwent liposuction. The swelling of the patient's right lower limb significantly improved after surgery. Epilepsy did not occur.after taking antiepileptic drugs and sirolimus. CONCLUSION: TSC with PLE is a rare and systemic disease. Imaging can detect lesions of this disease, which are important for diagnosis and treatment.
ABSTRACT
PURPOSE: The dermal rim sign (DRS) on nonenhanced magnetic resonance imaging has been shown to predict dermal backflow (DBF) in patients with secondary upper limb lymphedema. However, whether the DRS has the same effects on primary lower extremity lymphedema (PLEL) has not been clearly reported. Therefore, this study aimed to explore whether the DRS can be used to diagnose DBF on lymphoscintigraphy in patients with PLEL. METHODS: A total of 94 patients who were diagnosed with PLEL were recruited for this retrospective study from January 2022 to December 2023. All the patients were divided into two groups according to the lymphoscintigraphy findings: no DBF and DBF. The magnetic resonance imaging data of the two groups were recorded and statistically compared for the following indicators: range of lymphedema involvement (left, right, whole lower limbs, only thigh, only calf and ankle), signs of lymphedema (notable thickening of skin, parallel line sign, grid sign, honeycomb sign, band sign, lymph lake sign, crescent sign, DRS), and lymphedema measurement (skin thickness, band width). The DRS is characterized by notable thickening of the skin plus the grid sign and/or honeycomb sign, plus the band sign. RESULTS: The following statistically significant differences in the following indicators were found between the two groups (P < .05): notable skin thickening, parallel line sign, grid sign, honeycomb sign, band sign, DRS, skin thickness, and band width. The sensitivity, specificity, and accuracy for predicting for DBF with the DRS was 82%, 64%, and 77%, respectively. CONCLUSIONS: This study confirmed good consistency between the DRS and DBF from the perspective of imaging. This tool is suitable for children, adolescents, and patients with contraindications to lymphoscintigraphy. The DRS has important value in assessing the severity of PLEL. The DRS is suggested for the clinical use of combined surgical treatment of PLEL.
Subject(s)
Lower Extremity , Lymphedema , Lymphoscintigraphy , Magnetic Resonance Imaging , Predictive Value of Tests , Humans , Lymphedema/diagnostic imaging , Retrospective Studies , Female , Male , Middle Aged , Lower Extremity/blood supply , Adult , Aged , Reproducibility of Results , Young Adult , Skin/diagnostic imaging , Skin/blood supply , AdolescentABSTRACT
Venous cystic adventitial disease (VCAD) is a rare vascular anomaly located in the common femoral vein in most cases. We describe the case of a 59-year-old female patient with right leg edema who was misdiagnosed with deep vein thrombosis of the lower extremity at another hospital. Magnetic resonance angiography revealed a round mass in the popliteal vein, with a narrow lumen. Considering the location of the lesion, absence of a history of deep venous thrombosis and trauma, and clinical manifestations, the diagnosis is likely a popliteal vein adventitial cyst. Segmental popliteal vein resection and reconstruction were performed using a cylindrical great saphenous vein graft. No joint connection was found during the operation, and the postoperative pathology confirmed VCAD.
Subject(s)
Cysts , Vascular Diseases , Female , Humans , Middle Aged , Popliteal Vein/diagnostic imaging , Popliteal Vein/surgery , Cysts/diagnostic imaging , Cysts/surgery , Treatment Outcome , Vascular Diseases/diagnostic imaging , Vascular Diseases/surgery , Femoral Vein/diagnostic imaging , Femoral Vein/surgery , Femoral Vein/pathologyABSTRACT
OBJECTIVES: To explore the clinical value of subendometrial enhancement (SEE), irregular thin-layered peritumoral early enhancement (ITLPE) and focal irregular peritumoral early enhancement (FIPE) on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for myometrial invasion in patients with low-risk endometrial carcinoma. METHODS: Seventy-seven patients with low-risk endometrial carcinoma who preoperatively underwent DCE-MRI were included. Two radiologists independently evaluated and recorded the occurrences of SEE, ITLPE and FIPE on DCE-MRI in all patients. Interobserver agreement was calculated between the two radiologists, and the relationships between SEE, ITLPE, FIPE, and myometrial invasion were analyzed based on histologic findings. For statistically significant findings, the sensitivity and specificity were calculated, and the differences in myometrial invasion evaluations were analyzed. For those with no statistical significance, images were compared with the histopathologic sections. RESULTS: Inter-observer agreement was good (k = 0.80; 95%CI, 0.577-0.955) for SEE, and very good (k = 0.88; 95%CI, 0.761-0.972) (k = 0.86; 95%CI, 0.739-0.973) for ITLPE and FIPE. After consensus, SEE was identified in 12/77 (15.6%) patients; ITLPE and FIPE were found in 53/77 (68.8%) and 30/77 (39.0%) patients, respectively. SEE and ITLPE were significantly correlated with myometrial infiltration (P = 0.000), but FIPE were not (P = 0.725).The sensitivity and specificity of SEE and ITLPE for myometrial invasion in patients with low-risk endometrial carcinoma were 95.0 and 52.9%, and 85.0 and 88.0%, respectively. The area under the curve (AUC) of SEE and ITLPE for myometrial invasion were 0.740 (95%CI, 0.584-0.896), and 0.866 (95%CI, 0.763-0.970), respectively. The sensitivity and specificity were statistically different between SEE and ITLPE for the detection of myometrial invasion (P = 0.031, 0.016). According to the comparison between FIPE and histopathologic findings, the irregular endomyometrial junction was found in 30/77 (38.9%) cases, 24/30 (80.0%) with myometrial infiltration and 6/30 (20.0%) cases without myometrial infiltration. CONCLUSIONS: FIPE was the irregular endomyometrial junction. It can be found in patients with or without myometrial infiltration and may lead to the overestimation of myometrial invasion by SEE on DCE-MRI. ITLPE presented high diagnostic performance and specificity for myometrial invasion in patients with low-risk endometrial carcinoma.
ABSTRACT
BACKGROUND: Sarcomatoid carcinoma (SC) is a malignant tumour composed of spindle cells. The incidence of SC is low, especially in the uterus. The imaging features of uterine sarcomatoid carcinoma (USC) are rarely reported. We report a case of USC and discuss the dynamic contrast-enhanced MR (DCE-MR) and PET/CT findings. CASE PRESENTATION: A 69-year-old woman presented to the Department of Gynaecology with vaginal bleeding. Ultrasound examination discovered a heterogeneous mass in the cervix. Then, MRI examination of the pelvis was performed. On T2-weighted images, the uterus was replaced by an ill defined and diffuse lesion with inhomogeneous intensity. On T1-weighted images, the lesion appeared with signal hypointensity and was heterogeneously enhanced with contrast material. Additionally, enlarged lymph nodes were found in the pelvic cavity. PET/CT demonstrated high uptake in the region of the uterus and pelvic lymph nodes, which was consistent with MRI findings. The radiologists diagnosed the patient with malignant uterine lesions. The patient underwent hysterectomy and bilateral adnexectomy with pelvic lymph node dissection. Then, systemic radiotherapy and chemotherapy were performed. USC with lymph node metastasis was diagnosed with the help of immuno-histochemical analysis. There was no treatment related complication and no evidence of tumour recurrence at the postoperative 6-month follow-up. CONCLUSION: MRI and PET/CT features are sufficient to indicate the malignant nature of a USC, but they are not pathognomonic.
Subject(s)
Carcinoma/diagnostic imaging , Cervix Uteri/diagnostic imaging , Lymph Nodes/diagnostic imaging , Lymphatic Metastasis/diagnostic imaging , Magnetic Resonance Imaging/methods , Positron Emission Tomography Computed Tomography/methods , Uterine Hemorrhage/etiology , Uterine Neoplasms/diagnostic imaging , Aged , Antineoplastic Agents/therapeutic use , Carcinoma/pathology , Carcinoma/therapy , Chemoradiotherapy, Adjuvant , Combined Modality Therapy , Female , Humans , Lymphatic Metastasis/therapy , Neoplasm Recurrence, Local , Treatment Outcome , Uterine Neoplasms/pathology , Uterine Neoplasms/therapyABSTRACT
This study investigated the correlation between dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and intravoxel incoherent motion diffusion-weighted imaging (IVIM DWI) to differentiate thyroid nodules. Quantitative DCE-MRI parameters, including the transfer constant (K trans), rate constant (K ep) and volume fraction of the extracellular extravascular space (V e), were calculated. The diffusion coefficient (D), pseudo-diffusion coefficient (D* ), and perfusion fraction (f) were derived from biexponential fitting of IVIM DWI. A total of 38 nodules, including 22 malignant and 16 benign nodules, were analyzed. The K trans, K ep and V e for benign lesions were 1.32 ± 0.76 min-1, 6.44 ± 1.44 min-1, and 2.02 ± 0.89 min-1, respectively, and for malignant lesions, the values were 0.84 ± 0.30 min-1, 5.43 ± 1.38 min-1, and 1.71 ± 0.83 min-1, respectively (P = 0.027, 0.036, and 0.257, respectively). The D, f, and D* for benign lesions were 1.51 ± 0.52 mm2/s, 26.63 ± 8.75%, and 15.84 ± 8.71 mm2/s, respectively, and for malignant lesions, the values were 0.68 ± 0.17 mm2/s, 31.63 ± 10.72%, and 11.10 ± 4.21 mm2/s, respectively (P [< 0.0001, 0.135, 0.058], respectively). No significant correlations were found between IVIM DWI and DCE-MRI quantitative parameters (all P > 0.05). In benign nodules, a moderate inverse correlation was found between D and K ep (r = -0.54, P = 0.031). IVIM DWI shows no significant correlation with perfusion parameters derived from DCE-MRI; however, IVIM DWI combined with quantitative DCE-MRI may be a useful imaging tool for the assessment of thyroid nodules in clinical studies.
ABSTRACT
BACKGROUND: There is a growing need for a reproducible and effective imaging method for the quantitative differentiation of benign from malignant thyroid nodules. This study aimed to investigate the performances of intravoxel incoherent motion (IVIM) parameters and the apparent diffusion coefficient (ADC) in differentiating malignant from benign thyroid nodules derived from the most repeatable region of interest (ROI) delineation. METHODS: Forty-three patients with 46 pathologically confirmed thyroid nodules underwent diffusion-weighted imaging (DWI) with 8 b values. Two observers measured the intravoxel incoherent motion (IVIM) parameters (D, f and D*) and the apparent diffusion coefficient (ADC), ADC600 and ADC990 values using whole-lesion (W-L) ROI and IVIM parameters using single-section (S-S) ROI delineation. The intraclass correlation coefficients (ICCs) and Bland-Altman plots were used to evaluate the intra- and interobserver variability. The diagnostic performance of these parameters was evaluated by generating receiver operating characteristic (ROC) curves. RESULTS: The ICC values of all IVIM with W-L ROI delineation were higher than those with S-S ROI delineation, and excellent intra- and interobserver reproducibility was obtained. According to the Bland-Altman plots, the 95% limits of agreement of the IVIM parameters determined by the W-L ROIs revealed smaller absolute intra- and interobserver variability than those determined by S-S ROIs. The D and ADC600 values obtained from the W-L ROIs were the most powerful parameters in differentiating benign from the malignant nodules [area under the ROC curve = 0.962 and 0.970, P = 0.771]. CONCLUSIONS: The W-L ROI of the thyroid was considered an effective method for obtaining IVIM measurements with excellent reproducibility for differentiating benign from malignant nodules.
Subject(s)
Diffusion Magnetic Resonance Imaging/methods , Thyroid Nodule/diagnostic imaging , Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Observer Variation , ROC Curve , Reproducibility of Results , Young AdultABSTRACT
BACKGROUND: Hypobaric hypoxia (HH) exposure at high altitudes can result in a decline in cognitive function, which may have a serious impact on the daily life of people who migrate to high altitudes. However, the specific HH-induced changes in brain function remain unclear. This study explored changes in brain activity in rats exposed to a sustained HH environment using functional magnetic resonance imaging (fMRI). METHODS: Healthy male rats (8 weeks old) were randomly divided into a model group and a control group. A rat model of cognitive impairment induced by sustained HH exposure was established. The control and model groups completed training and testing in the Morris water maze (MWM). A two-sample t-test for between-group difference comparisons was performed. Repeated measures analyses of variance for within-group comparisons were performed and post-hoc comparisons were made using the Tukey test. Between-group differences in spontaneous brain activity were assessed using a voxel-wise analysis of resting-state fMRI (rs-fMRI), combined with analyses of the fractional amplitude of low frequency fluctuations (fALFF) in statistical parametric mapping. RESULTS: In the MWM test, the escape latencies of the model group were significantly longer compared with those of the control group (control group vs. model group, day 1: 21.6 ± 3.3âs vs. 40.5â±â3.4âs, tâ=â-11.282; day 2: 13.5â±â2.2âs vs. 28.7â±â5.3âs, tâ=â-7.492; day 3: 10.5â±â2.8âs vs. 22.6â±â6.1âs, tâ=â-5.099; day 4: 9.7â±â2.5âs vs. 18.6â±â5.2âs, tâ=â-4.363; day 5: 8.8â±â2.7âs vs. 16.7â±â5.0âs, tâ=â-3.932; all Pâ<â0.001). Within both groups, the escape latency at day 5 was significantly shorter than those at other time points (control group: Fâ=â57.317, Pâ<â0.001; model group: Fâ=â50.718, Pâ<â0.001). There was no within-group difference in average swimming speed (control group, Fâ=â1.162, Pâ=â0.956; model group, Fâ=â0.091, Pâ=â0.880). Within the model group, the time spent within the original platform quadrant was significantly shorter (control group vs. model group: 36.1â±â5.7âs vs. 17.8â±â4.3âs, tâ=â7.249, Pâ<â0.001) and the frequency of crossing the original platform quadrant was significantly reduced (control group vs. model group: 6.4â±â1.9âs vs. 2.0â±â0.8âs, tâ=â6.037, Pâ<â0.001) compared with the control group. In the rs-fMRI study, compared with the control group, rats in the model group showed widespread reductions in fALFF values throughout the brain. CONCLUSIONS: The abnormalities in spontaneous brain activity indicated by the fALFF measurements may reflect changes in brain function after HH exposure. This widespread abnormal brain activity may help to explain and to provide new insights into the mechanism underlying the impairment of brain function under sustained exposure to high altitudes.
Subject(s)
Cognitive Dysfunction/physiopathology , Magnetic Resonance Imaging/methods , Animals , Brain/metabolism , Brain/physiopathology , Cognition/physiology , Cognitive Dysfunction/metabolism , Hypoxia/metabolism , Hypoxia/physiopathology , Male , Maze Learning , RatsSubject(s)
Diffusion Magnetic Resonance Imaging/methods , Thyroid Nodule/diagnostic imaging , Thyroid Nodule/pathology , Adolescent , Adult , Aged , Diagnosis, Differential , Female , Humans , Male , Middle Aged , Motion , Reproducibility of Results , Sensitivity and Specificity , Thyroid Gland/diagnostic imaging , Thyroid Gland/pathology , Young AdultABSTRACT
IgG4-related disease (IgG4-RD) is recognized as an immune-mediated condition with pathology features of lymphoplasmacytic infiltrate, storiform fibrosis, and obliterative phlebitis, accompanied with or without elevated serum IgG4 concentrations. However, few of pulmonary artery IgG4-RD causing pulmonary hypertension (PH) was reported.The medical records of 3 patients with pulmonary artery IgG4-RD inducing PH were analyzed retrospectively.Imaging findings demonstrated that the lesions of 3 patients located in pulmonary artery, which were initially diagnosed as pulmonary thrombus or malignant tumor. Computed tomography pulmonary angiography (CTPA), ultrasonic cardiogram, and positron emission tomography/computed tomography (PET/CT) didn't support the diagnosis of pulmonary thrombus or malignant tumor. Right heart catheterization (RHC) showed definite PH. Biopsy by right heart catheterization in 2 patients or pneumonectomy in 1 patient confirmed the diagnosis as IgG4-RD. Treated with glucocorticoids and cyclophosphamide or rituximab, 2 patients' IgG4 concentrations declined sharply and the lesions shrunk gradually. Another patient treated with glucocorticoids died of heart failure.IgG4-RD involved pulmonary artery causing PH was rare. A high index of awareness of this disease is required for early diagnosis and treatment. PET/CT might be a valuable approach to distinguish pulmonary artery IgG4-RD from pulmonary thrombus and malignant tumor.
Subject(s)
Autoimmune Diseases/diagnosis , Hypertension, Pulmonary/diagnosis , Pulmonary Artery/pathology , Adult , Autoimmune Diseases/drug therapy , Cardiac Catheterization/methods , Computed Tomography Angiography/methods , Cyclophosphamide/therapeutic use , Diagnosis, Differential , Glucocorticoids/therapeutic use , Humans , Hypertension, Pulmonary/drug therapy , Hypertension, Pulmonary/etiology , Immunoglobulin G , Magnetic Resonance Imaging/methods , Male , Middle Aged , Positron Emission Tomography Computed Tomography/methods , Retrospective Studies , Rituximab/therapeutic useABSTRACT
The aim was to compare high-resolution computed tomography (HRCT) and thin-section magnetic resonance imaging (MRI) findings of facial nerve hemangioma. The HRCT and MRI characteristics of 17 facial nerve hemangiomas diagnosed between 2006 and 2013 were retrospectively analyzed. All patients included in the study suffered from a space-occupying lesion of soft tissues at the geniculate ganglion fossa. Affected nerve was compared for size and shape with the contralateral unaffected nerve. HRCT showed irregular expansion and broadening of the facial nerve canal, damage of the bone wall and destruction of adjacent bone, with "point"-like or "needle"-like calcifications in 14 cases. The average CT value was 320.9 ± 141.8 Hu. Fourteen patients had a widened labyrinthine segment; 6/17 had a tympanic segment widening; 2/17 had a greater superficial petrosal nerve canal involvement, and 2/17 had an affected internal auditory canal (IAC) segment. On MRI, all lesions were significantly enhanced due to high blood supply. Using 2D FSE T2WI, the lesion detection rate was 82.4 % (14/17). 3D fast imaging employing steady-state acquisition (3D FIESTA) revealed the lesions in all patients. HRCT showed that the average number of involved segments in the facial nerve canal was 2.41, while MRI revealed an average of 2.70 segments (P < 0.05). HRCT and MR findings of facial nerve hemangioma were typical, revealing irregular masses growing along the facial nerve canal, with calcifications and rich blood supply. Thin-section enhanced MRI was more accurate in lesion detection and assessment compared with HRCT.
Subject(s)
Facial Nerve Diseases/diagnosis , Facial Nerve , Hemangioma/diagnosis , Magnetic Resonance Imaging , Peripheral Nervous System Neoplasms/diagnosis , Tomography, X-Ray Computed , Adult , Facial Nerve/diagnostic imaging , Facial Nerve/pathology , Female , Humans , Male , Middle Aged , Retrospective StudiesABSTRACT
Epidural fibrosis resulted from epidural fat destruction following laminectomy operation is regarded as a main cause of failed back surgery syndrome, which represents one of the most common complications in spine surgery. Up to now, the effectiveness of currently available treatments to prevent such a syndrome is quite limited. In the present study, we aimed to restore epidural fat using adipose tissue engineered from adipose derived stem cells (ASCs) in a rabbit dorsal laminectomy model. ASCs isolated from subcutaneous fat were first expanded to passage 3, seeded on porous poly(lactic-co-glycolic acid, PLGA) scaffold and then adipogenically induced for 7 days in vitro to form cell-scaffold complex. Laminectomy sites were created at T13-L1 level in each animal. The laminectomy defect was implanted either with cell-scaffold complex or PLGA scaffold alone. Non-treated defect was also included as a control. The animals were subjected to MRI evaluation at 1, 12 and 24 weeks post-surgery, and sacrificed at 24 weeks for gross and histological observation. It was demonstrated by MRI evaluation that scar tissue of coarse and high density was formed within laminectomy site in PLGA alone and non-treated groups as early as 12 weeks. However, the defect implanted with engineered adipose had formed a continuous linear adipose tissue regenerated along the spinal cord at 24 weeks. Histologically, a distinct area of adipose tissue just overlaying the dura mater could be identified in cell-scaffold complex treated group at 24 weeks post-operation. Regeneration of epidural fat was further confirmed by positive Oil Red O staining. As to the defect treated with PLGA alone or left untreated, either fine or dense scar tissue adhering to the dura mater was observed. Moreover, we could track the implanted ASCs labeled by magnetic nanoparticles within epidural area for as long as four weeks by MRI detection. Thus, adipose tissue engineered from ASCs exhibited great potential in restoration of epidural fat to prevent formation of epidural fibrosis.